Poland · Delayed Price · Currency is PLN Medicofarma Biotech Statistics
Total Valuation
WSE:MDB has a market cap or net worth of PLN 32.97 million. The enterprise value is 32.95 million.
| Market Cap | 32.97M |
| Enterprise Value | 32.95M |
Important Dates
The last earnings date was Monday, November 10, 2025.
| Earnings Date | Nov 10, 2025 |
| Ex-Dividend Date | n/a |
Share Statistics
WSE:MDB has 67.98 million shares outstanding.
| Current Share Class | 67.98M |
| Shares Outstanding | 67.98M |
| Shares Change (YoY) | n/a |
| Shares Change (QoQ) | n/a |
| Owned by Insiders (%) | n/a |
| Owned by Institutions (%) | n/a |
| Float | 10.14M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 117.14 |
| PB Ratio | 6.93 |
| P/TBV Ratio | 7.02 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | -10.78 |
| EV / Sales | 117.07 |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 0.82
| Current Ratio | 0.82 |
| Quick Ratio | 0.82 |
| Debt / Equity | n/a |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | -13.70 |
Financial Efficiency
Return on equity (ROE) is -48.60% and return on invested capital (ROIC) is -28.60%.
| Return on Equity (ROE) | -48.60% |
| Return on Assets (ROA) | -14.59% |
| Return on Invested Capital (ROIC) | -28.60% |
| Return on Capital Employed (ROCE) | -37.43% |
| Revenue Per Employee | 18,763 |
| Profits Per Employee | -203,677 |
| Employee Count | 20 |
| Asset Turnover | 0.02 |
| Inventory Turnover | 547.28 |
Taxes
| Income Tax | -22,736 |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has increased by +18.29% in the last 52 weeks. The beta is 1.05, so WSE:MDB's price volatility has been similar to the market average.
| Beta (5Y) | 1.05 |
| 52-Week Price Change | +18.29% |
| 50-Day Moving Average | 0.65 |
| 200-Day Moving Average | 0.38 |
| Relative Strength Index (RSI) | 36.93 |
| Average Volume (20 Days) | 37,745 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, WSE:MDB had revenue of PLN 281,446 and -3.06 million in losses.
| Revenue | 281,446 |
| Gross Profit | -1.13M |
| Operating Income | -3.31M |
| Pretax Income | -3.08M |
| Net Income | -3.06M |
| EBITDA | -1.28M |
| EBIT | -3.31M |
| Earnings Per Share (EPS) | n/a |
Balance Sheet
The company has 21,435 in cash and n/a in debt, giving a net cash position of 21,435 or 0.00 per share.
| Cash & Cash Equivalents | 21,435 |
| Total Debt | n/a |
| Net Cash | 21,435 |
| Net Cash Per Share | 0.00 |
| Equity (Book Value) | 4.76M |
| Book Value Per Share | n/a |
| Working Capital | -876,050 |
Cash Flow
| Operating Cash Flow | -1.28M |
| Capital Expenditures | n/a |
| Free Cash Flow | n/a |
| FCF Per Share | n/a |
Margins
| Gross Margin | n/a |
| Operating Margin | -1,175.95% |
| Pretax Margin | -1,093.60% |
| Profit Margin | n/a |
| EBITDA Margin | n/a |
| EBIT Margin | n/a |
| FCF Margin | n/a |
Dividends & Yields
WSE:MDB does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | n/a |
| Shareholder Yield | n/a |
| Earnings Yield | -9.27% |
| FCF Yield | n/a |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | n/a |
| Graham Upside | n/a |
Stock Splits
The last stock split was on November 8, 2011. It was a reverse split with a ratio of 0.1.
| Last Split Date | Nov 8, 2011 |
| Split Type | Reverse |
| Split Ratio | 0.1 |
Scores
| Altman Z-Score | n/a |
| Piotroski F-Score | 1 |